Argus Research lowered its price target for chemical manufacturer Cabot Corporation (CBT) to $73.00, below the current stock price of $75.61. The company produces a range of chemicals, materials, and
Cabot Corp SVP and General Counsel Kalita Karen A received 31 derivative securities valued at $79.68 each on September 11, 2026. This award increases her total holdings by approximately 0.6%.
UBS Asset Management raised its Cabot Corporation holding by 16.4% to approximately $10 million in Q2. Cabot exceeded earnings estimates with $1.67 EPS and maintains a consensus Hold rating.
Jupiter Topco LLC recently acquired 23,283 shares of Cabot Corporation valued at $2.1 million. Meanwhile, CEO Sean Keohane sold over $11 million in shares despite the company exceeding Q2 earnings est
Wellington Management Group LLP disclosed beneficial ownership of 2.4 million Cabot Corporation shares, representing 4.68% of common stock. The filing details shared voting and dispositive power over
Cabot Corporation exceeded Q3 fiscal 2026 earnings estimates with $1.67 per share, while revenue grew 6.4% to $982 million driven by its Performance Chemicals segment. The company tightened earnings g
Eastern Bank reduced its stake in Cabot Corporation by 8.9% in Q2, selling 19,759 shares, while other institutional investors increased their holdings despite a consensus Hold rating.
Healthcare of Ontario Pension Plan reduced its Cabot Corporation stake by 67.5% in Q1, retaining shares worth $3.25 million. Cabot reported strong quarterly earnings exceeding estimates with positive
Cabot Corporation ranks first in the Chemicals industry with an institutional shareholding score of 10.00. ETHSX remains the largest shareholder, holding 1.22% of shares outstanding despite a slight q
Cabot Corporation achieved a financial health score of 8.05, placing 16th out of 65 in the chemicals industry. While quarterly revenue and net profit declined, the analysis notes robust overall financ
Cabot Corp outlines its major institutional shareholders, including BlackRock and Vanguard, providing insights into institutional ownership concentration.
Fifth Third Bancorp increased its Cabot Corporation stake by 312.5% to 49,248 shares worth $3.7 million, following strong Q2 earnings and a dividend announcement.
Cabot Corp director Douglas G. DelGrosso received 27.69 phantom stock units on June 12, 2026, increasing his total holdings to 5,164.95 units under the company's deferral plan.
ChemBrief